BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 23122802)

  • 41. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement.
    Watt M; Mealing S; Eaton J; Piazza N; Moat N; Brasseur P; Palmer S; Busca R; Sculpher M
    Heart; 2012 Mar; 98(5):370-6. PubMed ID: 22076021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimally Invasive Versus Transcatheter and Surgical Aortic Valve Replacement: A Propensity Matched Study.
    Terwelp MD; Thourani VH; Zhao Y; Balan P; Loghin C; Ocazionez D; Estrera A; Hoffmann CT; Babaliaros VC; Lamelas J; Nguyen TC
    J Heart Valve Dis; 2017 Mar; 26(2):146-154. PubMed ID: 28820543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial.
    Arnold SV; Lei Y; Reynolds MR; Magnuson EA; Suri RM; Tuzcu EM; Petersen JL; Douglas PS; Svensson LG; Gada H; Thourani VH; Kodali SK; Mack MJ; Leon MB; Cohen DJ;
    Circ Cardiovasc Interv; 2014 Dec; 7(6):829-36. PubMed ID: 25336467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Initiation of a Transcatheter Aortic Valve Replacement Program in the Treatment of Severe Aortic Stenosis.
    Ad N; Holmes SD; Shuman DJ; Rongione AJ; Massimiano PS; Speir AM; Pritchard G; Yazdani S; Raybuck BD
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):353-360. PubMed ID: 28043443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: summary assessment of the California Technology Assessment Forum.
    Tice JA; Sellke FW; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):482-91.e6. PubMed ID: 24252939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation.
    Rudolph V; Schirmer J; Franzen O; Schlüter M; Seiffert M; Treede H; Reichenspurner H; Blankenberg S; Baldus S
    Int J Cardiol; 2013 Aug; 167(3):716-20. PubMed ID: 22459381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of transcatheter valvular interventions: economic challenges.
    Osnabrugge RL; Kappetein AP; Reynolds MR; Cohen DJ
    EuroIntervention; 2013 Sep; 9 Suppl():S48-54. PubMed ID: 24025958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion.
    Binder RK; Barbanti M; Ye J; Toggweiler S; Tan J; Freeman M; Cheung A; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2014 May; 83(6):E221-6. PubMed ID: 24402965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
    Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
    Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis.
    Thakkar B; Patel A; Mohamad B; Patel NJ; Bhatt P; Bhimani R; Patel A; Arora S; Savani C; Solanki S; Sonani R; Patel S; Patel N; Deshmukh A; Mohamad T; Grines C; Cleman M; Mangi A; Forrest J; Badheka AO
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):955-62. PubMed ID: 26699085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality, economics, and national guidelines for transcatheter aortic valve replacement.
    Pollak PM; Mack MJ; Holmes DR
    Prog Cardiovasc Dis; 2014; 56(6):610-8. PubMed ID: 24838136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons.
    Makkar RR; Jilaihawi H; Mack M; Chakravarty T; Cohen DJ; Cheng W; Fontana GP; Bavaria JE; Thourani VH; Herrmann HC; Pichard A; Kapadia S; Babaliaros V; Whisenant BK; Kodali SK; Williams M; Trento A; Smith CR; Teirstein PS; Cohen MG; Xu K; Tuzcu EM; Webb JG; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(9):901-11. PubMed ID: 24161334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contemporary Costs Associated With Transcatheter Aortic Valve Replacement: A Propensity-Matched Cost Analysis.
    Ailawadi G; LaPar DJ; Speir AM; Ghanta RK; Yarboro LT; Crosby IK; Lim DS; Quader MA; Rich JB
    Ann Thorac Surg; 2016 Jan; 101(1):154-60; discussion 160. PubMed ID: 26409710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review.
    Daneault B; Kirtane AJ; Kodali SK; Williams MR; Genereux P; Reiss GR; Smith CR; Moses JW; Leon MB
    J Am Coll Cardiol; 2011 Nov; 58(21):2143-50. PubMed ID: 22078419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcatheter versus surgical aortic valve replacement in patients with prior coronary artery bypass graft operation: a PARTNER trial subgroup analysis.
    Greason KL; Mathew V; Suri RM; Holmes DR; Rihal CS; McAndrew T; Xu K; Mack M; Webb JG; Pichard A; Williams M; Leon MB; Svensson L; Thourani V; Smith CR
    Ann Thorac Surg; 2014 Jul; 98(1):1-7; discussion 7-8. PubMed ID: 24881859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation].
    Bartoli S; Saia F; Marrozzini C; Berti E; Guastaroba P; Fortuna D; Ciuca C; Moretti C; Marzocchi A; De Palma R
    G Ital Cardiol (Rome); 2012 Jan; 13(1):50-8. PubMed ID: 22322472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness considerations in transcatheter management of valvular heart disease.
    Gadey G; Reynolds MR
    Can J Cardiol; 2014 Sep; 30(9):1058-63. PubMed ID: 24999170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.